{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:59:15Z","timestamp":1771477155644,"version":"3.50.1"},"reference-count":51,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK102511"],"award-info":[{"award-number":["K23DK102511"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R03DK122240"],"award-info":[{"award-number":["R03DK122240"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Despite our understanding of diabetes as an established risk factor for progressive kidney disease and cardiac complications, the prognostic significance of prediabetes in patients with chronic kidney disease (CKD) remains largely unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Participants of the Chronic Renal Insufficiency Cohort (CRIC) were categorized as having normoglycemia, prediabetes, or diabetes according to fasting plasma glucose, glycated hemoglobin A1c (HbA1c), and treatment with antidiabetic drugs at baseline. Unadjusted and adjusted proportional hazards models were fit to estimate the association of prediabetes and diabetes (versus normoglycemia) with: (1) composite renal outcome (end-stage renal disease, 50% decline in estimated glomerular filtration rate to\u2005\u2264\u200515 mL\/min\/1.73 m2, or doubling of urine protein-to-creatinine ratio to\u2005\u2265\u20050.22 g\/g creatinine); (2) composite cardiovascular (CV) outcome (congestive heart failure, myocardial infarction or stroke); and (3) all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 3701 individuals analyzed, 945 were normoglycemic, 847 had prediabetes and 1909 had diabetes. The median follow-up was 7.5 years. Prediabetes was not associated with the composite renal outcome (adjusted hazard ratio [aHR] 1.13; 95% confidence interval [CI], 0.96\u20131.32; P\u2005=\u20050.14), but was associated with proteinuria progression (aHR 1.23; 95% CI, 1.03\u20131.47; P\u2005=\u20050.02). Prediabetes was associated with a higher risk of the composite CV outcome (aHR 1.38; 95% CI, 1.05\u20131.82; P\u2005=\u20050.02) and a trend towards all-cause mortality (aHR 1.28; 95% CI, 0.99\u20131.66; P\u2005= 0.07). Participants with diabetes had an increased risk of the composite renal outcome, the composite CV outcome, and all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In individuals with CKD, prediabetes was not associated with composite renal outcome, but was associated with an increased risk of proteinuria progression and adverse CV outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa017","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T14:34:36Z","timestamp":1579185276000},"page":"e1772-e1780","source":"Crossref","is-referenced-by-count":33,"title":["Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study"],"prefix":"10.1210","volume":"105","author":[{"given":"Jo\u00e3o S\u00e9rgio","family":"Neves","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o, Faculdade de Medicina, Universidade do Porto, Porto, Portugal"},{"name":"Departamento de Cirurgia e Fisiologia, Unidade de Investiga\u00e7\u00e3o Cardiovascular, Faculdade de Medicina, Universidade do Porto, Porto, Portugal"}]},{"given":"Simon","family":"Correa","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA"}]},{"given":"Rute","family":"Baeta Baptista","sequence":"additional","affiliation":[{"name":"Pediatrics Department, Hospital de Dona Estef\u00e2nia, Centro Hospitalar Universit\u00e1rio de Lisboa Central, Portugal"},{"name":"Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}]},{"given":"Miguel","family":"Bigotte Vieira","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio de Lisboa Central, Lisboa, Portugal"}]},{"given":"Sushrut S","family":"Waikar","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-0533","authenticated-orcid":false,"given":"Finnian R","family":"Mc Causland","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}]}],"member":"80","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"2021122209532745500_CIT0001","volume-title":"National Diabetes Statistics Report, 2017","author":"CDC","year":"2017"},{"key":"2021122209532745500_CIT0002","first-page":"CD012661","article-title":"Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia","volume":"10","author":"Richter","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"2021122209532745500_CIT0003","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract."},{"issue":"1","key":"2021122209532745500_CIT0004","first-page":"5","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","author":"Eknoyan","year":"2013","journal-title":"Kidney Int"},{"issue":"3S1","key":"2021122209532745500_CIT0005","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US renal data system 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"2021122209532745500_CIT0006","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","article-title":"Management of patients with diabetes and CKD: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"90","author":"Perkovic","year":"2016","journal-title":"Kidney Int."},{"key":"2021122209532745500_CIT0007","author":"Neves"},{"issue":"8","key":"2021122209532745500_CIT0008","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"2021122209532745500_CIT0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2021122209532745500_CIT0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12882-019-1307-0","article-title":"Association between prediabetes (defined by HbA1C, fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: a 9-year prospective cohort study","volume":"20","author":"Kim","year":"2019","journal-title":"BMC Nephrol."},{"issue":"11","key":"2021122209532745500_CIT0011","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2215\/CJN.01180117","article-title":"APOL1 risk variants, incident proteinuria, and subsequent eGFR decline in blacks with hypertension-attributed CKD","volume":"12","author":"Chen","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"2021122209532745500_CIT0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"JACC Heart Fail."},{"issue":"19","key":"2021122209532745500_CIT0013","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"Jama."},{"issue":"1","key":"2021122209532745500_CIT0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol."},{"issue":"21","key":"2021122209532745500_CIT0015","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med."},{"issue":"4","key":"2021122209532745500_CIT0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med."},{"issue":"22","key":"2021122209532745500_CIT0017","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med."},{"issue":"4","key":"2021122209532745500_CIT0018","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/HJH.0b013e32835eb5e8","article-title":"High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes","volume":"31","author":"Hellemons","year":"2013","journal-title":"J Hypertens."},{"issue":"8","key":"2021122209532745500_CIT0019","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.2337\/dc13-2625","article-title":"Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial","volume":"37","author":"Welsh","year":"2014","journal-title":"Diabetes Care."},{"issue":"6","key":"2021122209532745500_CIT0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2018.298489","article-title":"Cardiac and inflammatory biomarkers are associated with worsening renal outcomes in patients with type 2 diabetes mellitus: observations from SAVOR-TIMI 53","volume":"65","author":"Zelniker","year":"2019","journal-title":"Clin Chem."},{"issue":"7","key":"2021122209532745500_CIT0021","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dom.12630","article-title":"Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?","volume":"18","author":"Gallagher","year":"2016","journal-title":"Diabetes Obes Metab."},{"issue":"12","key":"2021122209532745500_CIT0022","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"2021122209532745500_CIT0023","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.16.11.1485","article-title":"Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity","volume":"16","author":"Metcalf","year":"1993","journal-title":"Diabetes Care."},{"issue":"6","key":"2021122209532745500_CIT0024","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1097\/01.ASN.0000015762.92814.85","article-title":"Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project","volume":"13","author":"Hoehner","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"2021122209532745500_CIT0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"2021122209532745500_CIT0026","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1464-5491.2004.01408.x","article-title":"A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects","volume":"22","author":"Wang","year":"2005","journal-title":"Diabet Med."},{"key":"2021122209532745500_CIT0027","article-title":"Impaired fasting glucose and chronic kidney disease, albuminuria, or worsening kidney function: a secondary analysis of the SPRINT","author":"Vieira","year":"2019;104(9):4024-4032","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021122209532745500_CIT0028","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/dme.13113","article-title":"Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis","volume":"33","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Diabet Med."},{"issue":"6","key":"2021122209532745500_CIT0029","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2215\/CJN.08540814","article-title":"Glycated hemoglobin level and mortality in a nondiabetic population with CKD","volume":"10","author":"Trivin","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"2021122209532745500_CIT0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","article-title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","volume":"7","author":"Coresh","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"2021122209532745500_CIT0031","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"2021122209532745500_CIT0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrcardio.2009.11","article-title":"Cardiovascular implications of proteinuria: an indicator of chronic kidney disease","volume":"6","author":"Agrawal","year":"2009","journal-title":"Nat Rev Cardiol."},{"issue":"1","key":"2021122209532745500_CIT0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11154-013-9239-7","article-title":"Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes","volume":"14","author":"Eringa","year":"2013","journal-title":"Rev Endocr Metab Disord."},{"issue":"1","key":"2021122209532745500_CIT0034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12350-016-0622-0","article-title":"Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism","volume":"25","author":"Nielsen","year":"2018","journal-title":"J Nucl Cardiol."},{"issue":"18","key":"2021122209532745500_CIT0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","article-title":"Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the maastricht study","volume":"134","author":"S\u00f6rensen","year":"2016","journal-title":"Circulation."},{"issue":"7","key":"2021122209532745500_CIT0036","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc14-3008","article-title":"Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes","volume":"38","author":"Grossmann","year":"2015","journal-title":"Diabetes Care."},{"issue":"2","key":"2021122209532745500_CIT0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.283.2.221","article-title":"Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study","volume":"283","author":"Meigs","year":"2000","journal-title":"Jama."},{"issue":"1","key":"2021122209532745500_CIT0038","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"2021122209532745500_CIT0039","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc15-1078","article-title":"Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in South Asians and Europeans","volume":"38","author":"Eastwood","year":"2015","journal-title":"Diabetes Care."},{"issue":"1","key":"2021122209532745500_CIT0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00125-012-2707-x","article-title":"Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus","volume":"56","author":"Sch\u00f6ttker","year":"2013","journal-title":"Diabetologia."},{"issue":"4","key":"2021122209532745500_CIT0041","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.ijcard.2013.05.038","article-title":"Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study","volume":"168","author":"Deedwania","year":"2013","journal-title":"Int J Cardiol."},{"key":"2021122209532745500_CIT0042","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"Bmj."},{"issue":"3","key":"2021122209532745500_CIT0043","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/diacare.28.3.607","article-title":"Blood glucose and heart failure in nondiabetic patients","volume":"28","author":"Nielson","year":"2005","journal-title":"Diabetes Care."},{"issue":"3","key":"2021122209532745500_CIT0044","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.114.001990","article-title":"Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the Atherosclerosis Risk In the Community study","volume":"8","author":"Skali","year":"2015","journal-title":"Circ Heart Fail."},{"issue":"4","key":"2021122209532745500_CIT0045","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"2021122209532745500_CIT0046","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med."},{"issue":"24","key":"2021122209532745500_CIT0047","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med."},{"issue":"11","key":"2021122209532745500_CIT0048","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta-analysis","volume":"95","author":"Tsai","year":"2016","journal-title":"Medicine."},{"issue":"5","key":"2021122209532745500_CIT0049","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.ajkd.2005.07.040","article-title":"The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden","volume":"46","author":"Evans","year":"2005","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"2021122209532745500_CIT0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2337\/dc13-0781","article-title":"Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009","volume":"37","author":"Chang","year":"2014","journal-title":"Diabetes Care."},{"issue":"9844","key":"2021122209532745500_CIT0051","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa017\/31860523\/dgaa017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1772\/41856709\/jcem_105_4_e1772.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/4\/e1772\/41856709\/jcem_105_4_e1772.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T17:51:41Z","timestamp":1640195501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/4\/e1772\/5707316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,1,16]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa017","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,1,16]]}}}